Shares probe ‘will clear ex-ISEQ boss’

AN investigation into the share dealings of a former Irish Stock Exchange director will uncover no impropriety, it was predicted last night.

Alltracel Pharmaceuticals’ chief executive Gerard Brandon confirmed yesterday that the London Stock Exchange is investigating the purchase of shares in Alltracel by company chairman Padraic O’Connor.

However, Mr Brandon said the investigation was routine in nature, and that he is confident that no impropriety has taken place in what he described as the perfectly legitimate purchase of shares by Mr O’Connor.